The estimated Net Worth of Michael Benkowitz is at least 15.3 百万$ dollars as of 7 August 2024. Mr. Benkowitz owns over 25,000 units of United Therapeutics Corp stock worth over 6,923,800$ and over the last 8 years he sold UTHR stock worth over 0$. In addition, he makes 8,383,190$ as President、 Chief Operating Officer at United Therapeutics Corp.
Michael has made over 39 trades of the United Therapeutics Corp stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 25,000 units of UTHR stock worth 2,960,250$ on 7 August 2024.
The largest trade he's ever made was exercising 32,200 units of United Therapeutics Corp stock on 6 May 2024 worth over 5,258,260$. On average, Michael trades about 5,078 units every 28 days since 2016. As of 7 August 2024 he still owns at least 20,000 units of United Therapeutics Corp stock.
You can see the complete history of Mr. Benkowitz stock trades at the bottom of the page.
Michael Benkowitz serves as President, Chief Operating Officer of the Company. He joined United Therapeutics in 2011 as Executive Vice President, Organizational Development. In this role, he was responsible for most companywide administrative functions, including human resources, information technology, corporate real estate and risk management, and was also responsible for many of our business development efforts and oversight of several of company key collaborations. He was promoted to President and Chief Operating Officer in June 2016, when he also became responsible for all of company commercial and medical affairs activities.
As the President、 Chief Operating Officer of United Therapeutics Corp, the total compensation of Michael Benkowitz at United Therapeutics Corp is 8,383,190$. There are 1 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of 15,627,500$.
Michael Benkowitz is 48, he's been the President、 Chief Operating Officer of United Therapeutics Corp since 2016. There are 20 older and no younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.
Michael's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.
Over the last 20 years, insiders at United Therapeutics Corp have traded over 68,910,395$ worth of United Therapeutics Corp stock and bought 229,703 units worth 13,655,671$ . The most active insiders traders include Martine A Rothblatt、David Zaccardelli、Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of 2,310,818$. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth 991,341$.
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
United Therapeutics Corp executives and other stock owners filed with the SEC include: